Filing Details

Accession Number:
0001144204-16-088278
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-15 17:57:46
Reporting Period:
2016-03-11
Filing Date:
2016-03-15
Accepted Time:
2016-03-15 17:57:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472091 Edge Therapeutics Inc. EDGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy C/o Sofinnova
000 Sand Hill Road, Bldng 4, Suite 250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-11 541,343 $7.30 2,852,711 No 4 P Indirect By Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fund
Footnotes
  1. Consists of 2,852,711 shares of common stock owned of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). The Reporting Person is a managing member of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership with regard to such shares, except to the extent of his proportionate pecuniary interest therein.